Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies. [electronic resource]
- Journal of virology Sep 2002
- 9253-9 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0022-538X
10.1128/jvi.76.18.9253-9259.2002 doi
Animals Anti-HIV Agents--pharmacology COS Cells Dose-Response Relationship, Drug Drug Resistance, Viral--genetics Genetic Vectors HIV Reverse Transcriptase--metabolism HIV-1--drug effects HeLa Cells Humans Hydroxyurea--pharmacology Lamivudine--pharmacology Mutation Reverse Transcriptase Inhibitors--pharmacology Thymidine--pharmacology Virus Replication Zidovudine--pharmacology